A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits

Abstract

The Onduo Virtual Diabetes Clinic (VDC) telehealth technology/care model for adults with type 2 diabetes (T2D) combines connected devices, remote lifestyle coaching, and clinical support with a mobile App. Key differentiating program features are the availability of live video consultations with board-certified endocrinologists for medication management and real-time continuous glucose monitor use for higher-risk participants. Preliminary data (n = 740) suggest that participation was associated with a significant improvement in HbA1c with up to 6 months follow-up in those not meeting treatment targets. HbA1c decreased by 2.3% ± 1.9%, 0.7% ± 1.0%, and 0.2% ± 0.8% across baseline categories of >9.0%, 8.0%-9.0% and 7.0% to <8.0%, respectively (all P < .001). These findings suggest that the VDC has potential to support individuals with T2D and their clinicians in diabetes management between office visits.

Keywords: A1c; connected care; digital health; mobile health; telemedicine; type 2 diabetes.

Figure 1.

Change in HbA1c from initial measurement to follow-up stratified by initial HbA1c range. Data are presented as mean ± SD. The initial HbA1c measurement was obtained within 30 days prior to or post enrollment and the follow-up HbA1c was defined as the most recent measurement obtained within 90 to 180 days from initial measurement. The mean follow-up time period was 4.2 months (125.6 ± 22.4 days). *P < .001.